DSEC

DSEC is a peer membership of over 2,000 drug safety leaders with the common objective of advancing the development of better and safer medicines. DSEC also manages three industry consortia: a Technology Evaluation Consortium to assess preclinical safety platforms; the Data Access Consortium to develop a solution for accessing legacy safety data, and a Software Validation Consortium to establish a better solution for validating GLP software.

DSEC is managed by Cambridge Healthtech Associates (CHA), the leading organizer and facilitator of consortia and communities in the life sciences industry. Learn more at www.drugsafetycouncil.org.